Xinyue Cui - Search Results

Year	Number of Results
2015	1
2016	1
2017	1
2018	1
2019	10
2020	6
2021	12
2022	9

1

How personal characteristics impact phishing susceptibility: The mediating role of mail processing.

Ge Y, Lu L, Cui X, Chen Z, Qu W. Ge Y, et al. Among authors: cui x. Appl Ergon. 2021 Nov;97:103526. doi: 10.1016/j.apergo.2021.103526. Epub 2021 Jul 8. Appl Ergon. 2021. PMID: 34246073

2

MUC16 facilitates cervical cancer progression via JAK2/STAT3 phosphorylation-mediated cyclooxygenase-2 expression.

Shen H, Guo M, Wang L, Cui X. Shen H, et al. Among authors: cui x. Genes Genomics. 2020 Feb;42(2):127-133. doi: 10.1007/s13258-019-00885-9. Epub 2019 Nov 17. Genes Genomics. 2020. PMID: 31736008

3

miR-302a-3p targets FMR1 to regulate pyroptosis of renal tubular epithelial cells induced by hypoxia-reoxygenation injury.

Bai T, Cui Y, Yang X, Cui X, Yan C, Tang Y, Cao X, Dong C. Bai T, et al. Among authors: cui x. Exp Physiol. 2021 Dec;106(12):2531-2541. doi: 10.1113/EP089887. Epub 2021 Nov 9. Exp Physiol. 2021. PMID: 34605097

4

Design and synthesis of a novel mitochondria-targeted osteosarcoma theranostic agent based on a PIM1 kinase inhibitor.

Yi X, Cao Z, Yuan Y, Li W, Cui X, Chen Z, Hu X, Yu A. Yi X, et al. Among authors: cui x. J Control Release. 2021 Apr 10;332:434-447. doi: 10.1016/j.jconrel.2021.02.028. Epub 2021 Mar 1. J Control Release. 2021. PMID: 33662457

5

Screening of lactate dehydrogenase inhibitor from bioactive compounds in natural products by electrophoretically mediated microanalysis.

Li W, Cui X, Chen Z. Li W, et al. Among authors: cui x. J Chromatogr A. 2021 Oct 25;1656:462554. doi: 10.1016/j.chroma.2021.462554. Epub 2021 Sep 15. J Chromatogr A. 2021. PMID: 34571279

6

Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics.

Jia F, Li Y, Deng X, Wang X, Cui X, Lu J, Pan Z, Wu Y. Jia F, et al. Among authors: cui x. J Nanobiotechnology. 2021 Aug 11;19(1):238. doi: 10.1186/s12951-021-00981-7. J Nanobiotechnology. 2021. PMID: 34380471 Free PMC article.

7

Self-assembling combretastatin A4 incorporated protamine/nanodiamond hybrids for combined anti-angiogenesis and mild photothermal therapy in liver cancer.

Li Y, Lu J, Deng X, Wang X, Jia F, Zhong S, Cui X, Pan Z, Shao L, Wu Y. Li Y, et al. Among authors: cui x. Nanotechnology. 2021 Aug 23;32(46). doi: 10.1088/1361-6528/ac1be0. Nanotechnology. 2021. PMID: 34371485

8

Multicomponent-assembled nanodiamond hybrids for targeted and imaging guided triple-negative breast cancer therapy via a ternary collaborative strategy.

Cui X, Deng X, Liang Z, Lu J, Shao L, Wang X, Jia F, Pan Z, Hu Q, Xiao X, Wu Y, Sheng W. Cui X, et al. Biomater Sci. 2021 May 18;9(10):3838-3850. doi: 10.1039/d1bm00283j. Biomater Sci. 2021. PMID: 33885068

9

Colloidally Stabilized DSPE-PEG-Glucose/Calcium Phosphate Hybrid Nanocomposites for Enhanced Photodynamic Cancer Therapy via Complementary Mitochondrial Ca²⁺ Overload and Autophagy Inhibition.

Wang X, Li Y, Deng X, Jia F, Cui X, Lu J, Pan Z, Wu Y. Wang X, et al. Among authors: cui x. ACS Appl Mater Interfaces. 2021 Aug 25;13(33):39112-39125. doi: 10.1021/acsami.1c11583. Epub 2021 Aug 12. ACS Appl Mater Interfaces. 2021. PMID: 34384220

10

Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy.

Liang Z, Cui X, Yang L, Hu Q, Li D, Zhang X, Han L, Shi S, Shen Y, Zhao W, Ju Q, Deng X, Wu Y, Sheng W. Liang Z, et al. Among authors: cui x. Int J Pharm. 2021 Oct 25;608:121091. doi: 10.1016/j.ijpharm.2021.121091. Epub 2021 Sep 20. Int J Pharm. 2021. PMID: 34555477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results